Jobs at Freenome

Why join Freenome? Freenome is a high-growth biotech company developing tests to detect cancer using a standard blood draw. To do this, Freenome uses a multiomics platform that combines tumor and non-tumor signals with machine learning to find cancer in its earliest, most-treatable stages.  Cancer is relentless. This is why Freenome is building the clinical, economic, and operational evidence...

Timing is everything!  If you are passionate about Freenome's mission and want to contribute in a meaningful way, we encourage you to submit your CV or resume.   About Freenome Freenome is on a mission to empower everyone with the tools they need to detect, treat, and ultimately prevent diseases.  By applying advanced machine learning techniques to recent breakthroughs in genomic science, Fre...

Why join Freenome? Freenome is a high-growth biotech company developing tests to detect cancer using a standard blood draw. To do this, Freenome uses a multiomics platform that combines tumor and non-tumor signals with machine learning to find cancer in its earliest, most-treatable stages.  Cancer is relentless. This is why Freenome is building the clinical, economic, and operational evidence...

Why join Freenome? Freenome is a high-growth biotech company developing tests to detect cancer using a standard blood draw. To do this, Freenome uses a multiomics platform that combines tumor and non-tumor signals with machine learning to find cancer in its earliest, most-treatable stages.  Cancer is relentless. This is why Freenome is building the clinical, economic, and operational evidence...

Why join Freenome? Freenome is a high-growth biotech company developing tests to detect cancer using a standard blood draw. To do this, Freenome uses a multiomics platform that combines tumor and non-tumor signals with machine learning to find cancer in its earliest, most-treatable stages.  Cancer is relentless. This is why Freenome is building the clinical, economic, and operational evidence...

Why join Freenome? Freenome is a high-growth biotech company developing tests to detect cancer using a standard blood draw. To do this, Freenome uses a multiomics platform that combines tumor and non-tumor signals with machine learning to find cancer in its earliest, most-treatable stages.  Cancer is relentless. This is why Freenome is building the clinical, economic, and operational evidence...